Giordano A, Kumthekar PU, Jin Q, Binboga Kurt B, et al. A phase II study of atezolizumab, pertuzumab, and high-dose trastuzumab for central nervous system metastases in patients with HER2-positive breast cancer. Clin Cancer Res 2024 Sep 3. doi: 10.1158/1078-0432.CCR-24-1161.
PMID: 39226397